Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2020) – 128.41
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI – 0.5
Average rejection rate (2021) – 81.35%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2013, vol. 50, nr 2, April-June, p. 229–237

Publication type: clinical case

Language: English

Exophytic Tumours of Skin of the Head – Case Study and Review of the Literature

Guzy egzofityczne skóry głowy – opis przypadków i przegląd piśmiennictwa

Agnieszka Socha1,A,B,E,F, Iwona Niedzielska1,A,E

1 Department of Maxillofacial and Oral Surgery, Silesian Medical University in Katowice, Poland

Abstract

Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) – the most common of nonmalanotic skin cancers are at the same time the most common cancers in general, rarely resulting in metastasis, but of great risk of local recurrence. The authors present factors which are responsible for developing nonmalanotic skin tumors, such as environmental factors (ultraviolet radiation, arsenic exposure, phototeraphy, radioteraphy) and endogenic (immunosuprecy, patient age, virus infection). They present review of proposed and used method of treatment BCC and SCC. In the following paper three cases of patients operated in their clinic are presented, which proves that there is a lack of social awareness of the necessity of treatment of such cancers and oncological vigilance among general practitioners. The authors want to stress the necessity for establishing algorithms of after surgery treatment and long term observation of patient treating for nonmalanotic skin cancers.

Streszczenie

Amelanotyczne nowotwory skóry, do których należą raki podstawnokomórkowe (BCC) i kolczystokomórkowe (SCC), są najczęściej spotykanymi nowotworami skóry, rzadko dającymi przerzuty, ale o dużym ryzyku wznowy miejscowej. W pracy przedstawiono czynniki wpływające na rozwój amelanotycznych guzów skóry, takie jak czynniki środowiskowe (promieniowanie ultrafioletowe, ekspozycja na arszenik, fototerapia, radioterapia) i wewnątrzpochodne (immunosupresja, wiek pacjenta, zakażenia wirusami). Dokonano przeglądu rekomendowanych i stosowanych metod leczenia zmian typu BCC i S CC skóry głowy. Przedstawiono także opis trzech przypadków operowanych w Klinice autorów, które przekonują, iż brak jest świadomości społecznej dotyczącej potrzeby leczenia takich zmian i czujności onkologicznej lekarzy pierwszego kontaktu. Autorzy zwracają uwagę na konieczność opracowania algorytmów postępowania pozabiegowego i długotrwałej obserwacji pacjentów leczonych z powodu amelanotycznych nowotworów skóry.

Key words

basal cell carcinoma, squamous cell carcinoma, dynamic phototeraphy, Mohs microsurgery, immunosupression

Słowa kluczowe

rak podstawnokomórkowy, rak kolczystokomórkowy, terapia fotodynamiczna, mikrochirurgia Mhosa, immunosupresja

References (35)

  1. Paradisi A., Waterboer T., Sampogna F., Tabolli S., Simoni S., Pawlita M., Abeni D.: Seropositivity for human papillomavirus and incidence of subsequent squamos cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br. J. Dermatol. 2011, 165, 782–791.
  2. Madan V., Lear J.T., Szeimies R-M.: Non-melanoma skin cancer. Lancet 2010, 375, 673–685.
  3. Gailani M.R., Bale A. E.: Developmental genes and cancer: role of patched in basal cell carcinoma of the skin. J. N atl. Cancer Inst. 1997, 89, 1103–1109.
  4. Samarasinghe V., Madan V., Lear J.T.: Focus on basal cell carcinoma. J. S kin Cancer 2011, doi:10.1155/2011/328615.
  5. Schroeder M., Kestlmeier R., Schlegel J., Trappe A.E.: Extensive cerebral invasion of a basal cell carcinoma of the scalp. Eur. J. S urg. Oncol. 2001, 27, 510–511.
  6. Masini C., Fuchs P.G., Gabrielli F., Stark S., Sera F., Ploner M., Melchi C.F., Primavera G., Pirchio G., Picconi O., Petasecca P., Cattaruzza M. S., Pfister H. J., Abeni D.: Papillomavirus infection and cutaneous squamos cell carcinoma in immunocompetent individuals. Arch. Dermatol. 2003, 139, 890–894.
  7. Nguyen P., Vin-Christian K., Ming M.E., Berger T.: Aggressive squamos cell carcinomas in person infected with the human imminodeficiency virus. Arch. Dermatol. 2002, 138, 758–763.
  8. N akayama M., Tabuchi K., Nakamura Y., Hara A.: Basal cell carcinoma of head and neck. J. S kin Cancer. 2011, doi:10.1155/2011/496910.
  9. Barolet D., Boucher A.: No-needle jet intradermal aminolevulinic acid photodynamic therapy for recurrent nodular basal cell carcinoma of the nose: a case report. J. S kin Cancer 2011, doi:10.1155/2011/790509.
  10. Harwood M., Wu H., Tanabe K., Bercovitch L.: Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy. J. Am. Acad. Dermatol. 2005, 53, 475–478.
  11. Lesiak A., Słowik-Rylska M., Bogaczewicz J., Jochymski C., Kozłowski W., Sysa-Jędrzejowska A., Rogowski-Tylman M., Narbutt J.: Expression of selected cell cycle-related suppressor proteins in superficial and nodular sybtypes of basal cell carcinoma. Dermatol. Clin. 2008, 10, 185–189.
  12. Wang S.Q., Goldberg L.H.: Multiple polypoid basal cell carcinomas on the perineum of a patient with basal cell nevus syndrome. J. A m. Acad. Dermatol. 2007, 57, 36–37.
  13. Kaczmarzyk T., Stypułkowska J., Tomaszewska R., Czopek J.: Tumor odontogenes and tumor like laesions of jaws bones. Eds.: Quintessence 2009, 83–85.
  14. Ducic Y., Marra D.E.: Metastatic basal cell carcinoma. Am. J. Otolaryngol. Head Neck Med. Surg. 2011, 32, 455–458.
  15. Brzeziński P., Poklękowska K.: Morbus Boweni – clinic, dermathoscopy, histopathology. N. Dermatol. Online 2011, 2, 154–155.
  16. Kar B. R., Nair V., Ebenezer G., Job C.K.: Squamous cell carcinoma of the scalp arising from chronic cutaneous lupus erythematosus: report of two indian patients. Indian J. Dermatol. Venereol. Leprol. 2004, 70, 236–238.
  17. Johson H., Bossenbroek N., Rosenman K., Meehan S., Robles M., Pomeranz M.: Chronic cutaneous lupus erythematosus in vitiligo. Dermatol. Online J. 2008 14, 10–12.
  18. Daldon P. E., Macedo de Souza E., Cintra M. L.: Hypertrophic lupus erythematosus: a clinicopathological study of 14 cases. J. Cutan. Pathol. 2003, 30, 443–448.
  19. Rangwala S., Tsai K.Y.: Roles of the immune system in skin cancer. Br. J. Dermatol. 2011, 165, 953–965.
  20. Lorenzini M., Gatti S., Giannitrapani A.: Giant basal cell carcinoma of the thoracic wall: a case report and review of the literature. Br. J. Plastic Surg. 2005, 58, 1007–1010.
  21. Archontaki M., Stavrianos S., Korkolis D., Arnogiannaki N., Vassiliadis V., Liapakis I., Christ H., Rapidis A., Kokkalis G.: Giant basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res. 2009, 29, 2655–2664.
  22. Padilla S.R., Sebastian S., Jiang Z., Nindl I., Larson R.: Gene expression patterns of normal human skin, actinic keratosis, and squamos cell carcinoma. Arch. Dermatol. 2010, 146, 288–293.
  23. Berlin J., Katz K.H., Helm K.F., Maloney M.E.: The significance of tumor persistence after incomplete excision of basal cell carcinoma. J. A m. Acad. Dermatol. 2002, 46, 549–553.
  24. Hansen C., Wilkinson D., Hansen M., Soyer P.: Factor contributing to incomplete excision of nonmelanoma skin cancer by australian general practitioners. Arch. Dermatol. 2009, 145, 1253–1260.
  25. Gohari S., Gambla C., Healey M., Spaulding G., Gordon K.B., Swan J., Cook B., West D.P., Lapiere J-CH.: Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol. Surg. 2002, 28, 1107–1114.
  26. Sobjanek M., Kozicka D., Michajłowski I., Drogoszewska B., Kolano P., Włodarkiewicz A., Roszkiewicz J.: Skin cancers of the auricle: clinical, histological and surgical treatment analysis of 100 patients. Dermatol. Clin. 2011, 13, 127–132.
  27. Dudra-Jastrzębska M.: Micrographic surgery by Mohs´ Method. New Med. 2007, 3, 66–71.
  28. Chiller K., Passaro D., McCalmont T., Vin-Christian K.: Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer. Arch. Dermatol. 2000, 136, 1327–1332.
  29. Agostinis P., Berg K., Cengel K. A., Foster T. H., Girotti A.W., Gollnick S. O., Hahn S.M., Hamblin M. D., Juzeniene A., Kessel D., Korbelik M., Moan J., Mroz P., Nowis D., Piette J., Wilson B. C., Golab J., Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 2011, 61, 250–281.
  30. Brown V., Atkins C., Ghali L., Cerio R., Harwood C., Proby Ch.: Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients. Arch Dermatol. 2005, 141, 985–993.
  31. Takaoka K., Noguchi K., Toyohara Y., Hiromoto T., Okui S., Sakurai K., Urade M.: Keratotic basal cell carcinoma of the tongue: case report. Br. J. Oral Maxillofac. Surg. 2009, 47, 230–232.
  32. Zhang W., Hanks A. N., Boucher K., Florell S.R., Allen S. M., Brash D. E., Grossman D.: UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis 2005, 26, 249–257.
  33. Frey L.M., Houben R., Brocker E-B.: Pigmentation, melanocyte colonization, and p53 status in basal cell carcinoma. J. S kin Cancer 2011, doi:10.1155/2011/349726.
  34. Lam Ch-W., Xie J., To K-F., Ng H-K., Lee K-Ch., Yuen N., Lim P-L., Chan L., Tong S-F, McCormik F.: A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 1999, 18, 833–836.
  35. Flohil S.C., Koljenović S., de Haas E.R.M., Overbeek L.I.H., de Veris E., Nijsten T.: Cumulative risk and rates of subsequent basal cell carcinomas in the Netherlands. Br. J. Dermatol. 2011, 165, 874–881.